Literature DB >> 4718816

[Simplified radiologic factor XIII determination and its clinical use in congenital factor XIII deficiency (I)].

R Egbring, W Schmidt, K Havemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4718816     DOI： 10.1007/BF01631421

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  13 in total

1.  [An unknown action of blood platelets; preliminary communication].

Authors:  K BULUK
Journal:  Pol Tyg Lek (Wars)       Date:  1955-02-07

2.  [Fibrin-stabilizing factor from thrombocytes].

Authors:  E F LUSCHER
Journal:  Schweiz Med Wochenschr       Date:  1957-10-02

3.  A TRANSAMIDASE MECHANISM FOR INSOLUBLE FIBRIN FORMATION.

Authors:  A G Loewy; J E Dahlberg; W V Dorwart; M J Weber; J Eisele
Journal:  Biochem Biophys Res Commun       Date:  1964-03-09       Impact factor: 3.575

4.  [Substitution treatment of factor XIII deficiency with a new factor XIII concentrate].

Authors:  H Trobisch; R Egbring
Journal:  Dtsch Med Wochenschr       Date:  1972-03-31       Impact factor: 0.628

5.  Factor 13 and antiplasmin activity in human platelets.

Authors:  J McDonagh; T H Kiesselbach; R H Wagner
Journal:  Am J Physiol       Date:  1969-03

6.  Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility.

Authors:  A Dvilansky; A F Britten; A G Loewy
Journal:  Br J Haematol       Date:  1970-04       Impact factor: 6.998

7.  [Plasma transglutaminase activity in congenital total and partial factor XIII deficiency (a contribution to the problem of factor XIII determination)].

Authors:  R Egbring; K Andrassy; H Egli
Journal:  Thromb Diath Haemorrh       Date:  1971

8.  [Diagnostic and therapeutic problems in congenital afibrinogenemia].

Authors:  R Egbring; K Andrassy; H Egli; J Meyer-Lindenberg
Journal:  Blut       Date:  1971-04

9.  Factor XIII in human plasma and platelets.

Authors:  J McDonagh; R P McDonagh; J M Delâge; R H Wagner
Journal:  J Clin Invest       Date:  1969-05       Impact factor: 14.808

10.  Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.

Authors:  L Lorand; T Urayama; J W De Kiewiet; H L Nossel
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808
View more
  8 in total

1.  Immunohistochemistry of secretory transglutaminase from rodent prostate.

Authors:  J Seitz; C Keppler; U Rausch; G Aumüller
Journal:  Histochemistry       Date:  1990

Review 2.  The human fibrin-stabilizing factors.

Authors:  H Bohn
Journal:  Mol Cell Biochem       Date:  1978-06-28       Impact factor: 3.396

Review 3.  [Blood coagulation factor XIII and fibrin stabilization (author's transl)].

Authors:  H Rasche
Journal:  Klin Wochenschr       Date:  1975-12-15

4.  [Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate].

Authors:  R Egbring; K Andrassy; K Havemann; G Fuchs; B Ruf; K Schander; H Trobisch
Journal:  Blut       Date:  1976-12

5.  Influences of thrombin, factor XIII and fibronectin on the growth of tumor cells and leukemic cells in vitro.

Authors:  H D Bruhn; R Bernsmeier; P Lück; K H Zurborn; E Christophers
Journal:  Klin Wochenschr       Date:  1983-02-15

6.  [Severe factor XIII-deficiency. Studies on subunits and turnover of the fibrin stabilizing factor (author's transl)].

Authors:  R Zimmermann; W Ehlers; F Manz; W Meinrenken; R Egbring; H Gemmeke
Journal:  Blut       Date:  1977-12

7.  Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses. Behaviour before and during treatment according to Protocol I of the Cooperative Leukaemia Study COALL-80.

Authors:  M Reitz; G Witzke; R Egbring; P Gutjahr
Journal:  Klin Wochenschr       Date:  1984-12-17

8.  Fibrinogen Marburg a new genetic variant of fibrinogen.

Authors:  G Fuchs; R Egbring; K Havemann
Journal:  Blut       Date:  1977-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.